Delivery Order SPE2DB22D1106-SPE2DB24FFBA5
Award Date
7/9/24
Potential Completion Date
7/30/24
Potential Value
$57K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of DARZALEX FASPRO, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award has a ceiling value of $11,040.84 and a completion date of June 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The contract, valued at $44,163.36, was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 13, 2024, with a completion date of July 8, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $110,408.40 firm-fixed-price delivery order is for the supply of 4,565,683,425 units of the medication DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has an ultimate completion date of September 25, 2024 and was awarded on September 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,204.20 delivery order contract is for the supply of DARZALEX FASPRO, a 1,800mg/30,000 15ml specialty pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of November 14, 2024. This award is associated with Amerisourcebergen's larger Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has a ceiling value of $82,806.30 and a period of performance through June 28, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), under an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $16,561.26 firm fixed price delivery order contract has an ultimate completion date of October 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $55,204.20 firm-fixed-price delivery order is for the supply of 4,566,078,093 units of the prescription drug DARZALEX FASPRO, a 1,800mg/30,000 15mL vial. The contract has an ultimate completion date of November 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of DARZALEX FASPRO, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $57,112.20 contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 18, 2024. The contract is a firm fixed-price Delivery Order with a completion date of January 10, 2025. This award is likely part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of the pharmaceutical product DARZALEX FASPRO 1,800mg-30,000 15ml to the Defense Logistics Agency (DLA). The contract, valued at $55,204.20, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 7, 2024. The contract has a completion date of August 28, 2024 and is a firm fixed price delivery order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DARZALEX FASPRO, a specialty medication, and has a ceiling value of $26,838.80. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of December 18, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...